Hospital
Firelands Regional Medical Center
Firelands Regional Medical Center was paid $37.47M by Medicaid between Jan 2018 and Dec 2024, across 367 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoFIRELANDS REGIONAL MEDICAL CENTER
SANDUSKY, OH 44870
SANDUSKY, OH 44870
33aNPI1801884655assigned 10/06/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$37.47M
24GClaims943,481
24DCodes billed367
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#31 of 101
Median peer was paid$22.32M
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 91,268 | $2.62M | |
| 2019 | 85,243 | $2.52M | |
| 2020 | 57,007 | $2.28M | |
| 2021 | 80,971 | $2.94M | |
| 2022 | 90,248 | $3.38M | |
| 2023 | 312,230 | $13.76M | |
| 2024incomplete | 226,514 | $9.98M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 77,325 | 69,648 | $8.52M |
| 96361 | Intravenous infusion, hydration; each additional hour | 9.6% | 13,062 | 10,820 | $3.62M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.2% | 22,760 | 20,431 | $2.68M |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 5.2% | 16,227 | 10,819 | $1.94M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5.0% | 34,780 | 27,005 | $1.89M |
| H2019 | Therapeutic behavioral services, billed per 15 minutesTherapeutic behavioral services, per 15 minutes | 3.9% | 18,720 | 10,666 | $1.46M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.6% | 8,027 | 6,582 | $992K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.5% | 6,982 | 6,293 | $948K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.5% | 9,636 | 9,041 | $920K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.4% | 13,314 | 3,233 | $911K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.0% | 11,891 | 3,576 | $740K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.9% | 2,773 | 2,338 | $696K |
355 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.7% | 2,583 | $620K |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.5% | 4,245 | $565K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.5% | 4,879 | $564K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.3% | 7,006 | $482K |
| 90791 | Psychiatric diagnostic evaluation | 1.3% | 2,298 | $479K |
| 90832 | Psychotherapy session, about 30 minutes | 1.2% | 4,982 | $454K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 1,633 | $421K |
| 80053 | Comprehensive metabolic panel | 1.0% | 32,882 | $393K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.0% | 4,824 | $390K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.0% | 3,773 | $389K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.0% | 2,909 | $381K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,799 | $363K |
| H2020 | Therapeutic behavioral services, per diem | <1% | 3,627 | $359K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,429 | $291K |
| 90839 | <1% | 1,913 | $230K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 656 | $226K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 38,905 | $225K |
| 99285 | Emergency room visit (most serious) | <1% | 1,871 | $222K |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | <1% | 2,868 | $217K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 747 | $187K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 960 | $166K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 383 | $161K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 1,163 | $159K |
| 59050 | <1% | 1,098 | $150K | |
| G0378 | Hospital observation service, per hour | <1% | 1,759 | $144K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 52,852 | $131K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,562 | $128K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 17,942 | $117K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 1,351 | $112K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,475 | $102K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 179 | $101K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 372 | $95K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 4,077 | $90K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 377 | $87K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 181 | $79K |
| H0036 | Community psychiatric support and treatment, per 15 minutes | <1% | 3,151 | $77K |
| 80061 | Lipid panel | <1% | 6,189 | $77K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 952 | $67K |
| 84439 | <1% | 3,147 | $67K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 10,649 | $65K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 731 | $65K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,898 | $62K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,487 | $55K |
| 36415 | Collection of venous blood by venipuncture | <1% | 60,315 | $54K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,031 | $52K |
| 93971 | <1% | 1,384 | $48K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 374 | $45K |
| 97161 | <1% | 842 | $44K | |
| S9470 | Nutritional counseling, dietitian visit | <1% | 588 | $43K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 6,200 | $41K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 354 | $40K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,501 | $40K |
| 82607 | <1% | 1,996 | $39K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 23,684 | $38K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,096 | $38K |
| 97162 | <1% | 651 | $37K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 64 | $35K |
| H0006 | Alcohol and/or drug services; case management | <1% | 955 | $34K |
| 96367 | <1% | 554 | $33K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 300 | $32K |
| 94060 | <1% | 227 | $31K | |
| 82728 | <1% | 1,943 | $31K | |
| 12001 | <1% | 220 | $30K | |
| 97113 | <1% | 456 | $29K | |
| 73130 | <1% | 876 | $29K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,092 | $29K |
| 97116 | <1% | 919 | $29K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 903 | $28K |
| 76642 | <1% | 223 | $27K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 166 | $26K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 952 | $26K |
| 90840 | <1% | 1,396 | $26K | |
| 70496 | <1% | 137 | $25K | |
| 73030 | <1% | 917 | $25K | |
| 76775 | <1% | 298 | $24K | |
| 64635 | <1% | 123 | $23K | |
| 93970 | <1% | 555 | $23K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,193 | $23K |
| 83540 | <1% | 2,285 | $22K | |
| 73610 | <1% | 876 | $21K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 17 | $21K |
| 64493 | <1% | 80 | $21K | |
| 72110 | <1% | 581 | $20K | |
| 73564 | <1% | 894 | $20K | |
| 84484 | <1% | 10,117 | $19K | |
| 74018 | <1% | 714 | $18K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 383 | $18K |
| 73560 | <1% | 473 | $18K | |
| 43235 | <1% | 49 | $18K | |
| 96415 | <1% | 74 | $18K | |
| 91200 | <1% | 174 | $18K | |
| 92523 | <1% | 264 | $17K | |
| 72050 | <1% | 381 | $17K | |
| 73630 | <1% | 940 | $17K | |
| 83550 | <1% | 2,061 | $16K | |
| 97165 | <1% | 292 | $16K | |
| 73110 | <1% | 475 | $16K | |
| 97016 | <1% | 532 | $15K | |
| 94729 | <1% | 248 | $15K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 468 | $15K |
| 94726 | <1% | 228 | $15K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 525 | $14K |
| 73502 | <1% | 602 | $14K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 17,802 | $14K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 850 | $13K |
| 86850 | <1% | 672 | $13K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 15,256 | $13K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 147 | $13K |
| 86703 | <1% | 585 | $13K | |
| 80076 | <1% | 5,181 | $12K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 960 | $12K |
| 81001 | <1% | 23,399 | $12K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 837 | $12K |
| 90785 | <1% | 450 | $12K | |
| 71045 | Radiologic examination, chest; single view | <1% | 6,548 | $12K |
| 82746 | <1% | 1,299 | $11K | |
| 86038 | <1% | 462 | $11K | |
| J3490 | Unclassified drugs | <1% | 3,278 | $11K |
| 83970 | <1% | 450 | $11K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 299 | $11K |
| 86140 | <1% | 1,146 | $10K | |
| 87081 | <1% | 1,383 | $10K | |
| 76830 | Ultrasound, transvaginal | <1% | 215 | $10K |
| 86900 | <1% | 844 | $10K | |
| 84702 | <1% | 711 | $10K | |
| 0002A | <1% | 260 | $10K | |
| 0001A | <1% | 285 | $9K | |
| 84153 | <1% | 513 | $9K | |
| 97597 | <1% | 628 | $9K | |
| 82805 | <1% | 241 | $9K | |
| 82553 | <1% | 1,371 | $9K | |
| 90870 | <1% | 25 | $9K | |
| 36591 | <1% | 870 | $9K | |
| 72100 | <1% | 267 | $8K | |
| H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | <1% | 1,628 | $8K |
| 82570 | <1% | 1,035 | $8K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,394 | $8K |
| 86803 | <1% | 528 | $8K | |
| 83735 | <1% | 3,687 | $8K | |
| 97014 | <1% | 253 | $7K | |
| 87070 | <1% | 867 | $7K | |
| 85610 | <1% | 9,342 | $7K | |
| 88307 | <1% | 69 | $7K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 93 | $7K |
| 70486 | <1% | 123 | $6K | |
| 87186 | <1% | 1,790 | $6K | |
| 85027 | <1% | 1,504 | $6K | |
| 71250 | <1% | 118 | $6K | |
| 90715 | <1% | 469 | $6K | |
| 83880 | <1% | 3,042 | $6K | |
| 76801 | <1% | 99 | $6K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 12 | $6K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 42 | $6K |
| 12011 | <1% | 43 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 11,319 | $6K |
| 93017 | <1% | 60 | $5K | |
| 87340 | <1% | 291 | $5K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 343 | $5K |
| 87088 | <1% | 1,611 | $5K | |
| 88304 | <1% | 346 | $5K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 29 | $5K |
| 85652 | <1% | 1,287 | $5K | |
| 73100 | <1% | 107 | $5K | |
| 76536 | <1% | 53 | $5K | |
| 82043 | <1% | 782 | $5K | |
| 80069 | <1% | 456 | $4K | |
| 97166 | <1% | 85 | $4K | |
| 92609 | <1% | 101 | $4K | |
| 87486 | <1% | 94 | $4K | |
| 84481 | <1% | 357 | $4K | |
| 72114 | <1% | 76 | $4K | |
| 87481 | <1% | 200 | $4K | |
| 87077 | <1% | 713 | $4K | |
| 86592 | <1% | 197 | $4K | |
| 73590 | <1% | 218 | $4K | |
| 84436 | <1% | 245 | $4K | |
| 81003 | <1% | 5,483 | $4K | |
| 82948 | <1% | 3,143 | $3K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 174 | $3K |
| T1002 | Rn services, up to 15 minutes | <1% | 332 | $3K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 28 | $3K |
| 81025 | <1% | 13,369 | $3K | |
| 83690 | <1% | 10,730 | $3K | |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | <1% | 86 | $3K |
| 10061 | <1% | 24 | $3K | |
| 70498 | <1% | 132 | $3K | |
| 86901 | <1% | 845 | $3K | |
| 10060 | <1% | 17 | $3K | |
| 82550 | <1% | 4,632 | $3K | |
| 73090 | <1% | 116 | $3K | |
| 82565 | <1% | 778 | $3K | |
| 82731 | <1% | 112 | $3K | |
| 82784 | <1% | 246 | $3K | |
| 84550 | <1% | 510 | $3K | |
| 93880 | <1% | 100 | $3K | |
| 87522 | Neg quan hep c or qual rna | <1% | 79 | $3K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 126 | $3K |
| 85007 | <1% | 759 | $3K | |
| 84466 | <1% | 161 | $3K | |
| 73080 | <1% | 138 | $3K | |
| 82533 | <1% | 138 | $2K | |
| 83721 | <1% | 182 | $2K | |
| 84146 | <1% | 348 | $2K | |
| 88341 | <1% | 39 | $2K | |
| 86706 | <1% | 129 | $2K | |
| 85730 | <1% | 6,382 | $2K | |
| 87581 | <1% | 94 | $2K | |
| 00731 | <1% | 640 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,803 | $2K |
| 82150 | <1% | 1,903 | $2K | |
| 73562 | <1% | 40 | $2K | |
| G0008 | Administration of influenza virus vaccine | <1% | 68 | $2K |
| 72170 | <1% | 78 | $2K | |
| 80320 | <1% | 102 | $2K | |
| 93225 | <1% | 14 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 545 | $2K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 27 | $2K |
| 88342 | <1% | 386 | $2K | |
| 82077 | <1% | 2,103 | $1K | |
| 84480 | <1% | 120 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 67 | $1K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 5,212 | $1K |
| 86376 | <1% | 68 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 26 | $1K |
| 96376 | <1% | 1,533 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 6,563 | $1K |
| 87205 | <1% | 744 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,570 | $1K |
| 72072 | <1% | 44 | $1K | |
| 72131 | <1% | 20 | $1K | |
| 84450 | <1% | 202 | $1K | |
| 86704 | <1% | 53 | $1K | |
| H2012 | Behavioral health day treatment, per hour | <1% | 33 | $1K |
| 82248 | <1% | 408 | $990.83 | |
| 83655 | <1% | 31 | $979.49 | |
| 36416 | <1% | 3,727 | $939.14 | |
| 87040 | <1% | 1,348 | $917.18 | |
| 90686 | <1% | 62 | $858.69 | |
| 87071 | <1% | 175 | $855.31 | |
| 73140 | <1% | 30 | $851.87 | |
| Q3014 | Telehealth originating site facility fee | <1% | 67 | $843.88 |
| 84100 | <1% | 257 | $842.36 | |
| 83605 | <1% | 955 | $834.30 | |
| 93226 | <1% | 14 | $811.05 | |
| 84156 | <1% | 280 | $784.35 | |
| 84403 | <1% | 79 | $767.12 | |
| 87109 | <1% | 30 | $765.00 | |
| 86431 | <1% | 60 | $762.47 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,753 | $751.82 |
| 84703 | <1% | 411 | $731.46 | |
| 96523 | <1% | 23 | $705.06 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12,375 | $651.58 |
| 87427 | <1% | 60 | $645.88 | |
| 94375 | <1% | 378 | $632.62 | |
| 87045 | <1% | 31 | $630.20 | |
| 93922 | <1% | 12 | $624.18 | |
| 87046 | <1% | 59 | $614.48 | |
| 85379 | <1% | 911 | $613.32 | |
| 86364 | <1% | 53 | $608.38 | |
| 87493 | <1% | 15 | $583.91 | |
| 73552 | <1% | 26 | $570.56 | |
| 94010 | <1% | 12 | $567.17 | |
| 84520 | <1% | 255 | $556.45 | |
| 86231 | <1% | 27 | $543.34 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,414 | $531.14 |
| 93923 | <1% | 27 | $521.36 | |
| 84402 | <1% | 28 | $510.60 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,296 | $493.75 |
| 85014 | <1% | 126 | $475.44 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 2,159 | $455.26 |
| 87210 | <1% | 376 | $398.50 | |
| 0031A | <1% | 23 | $398.31 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 414 | $388.73 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 5,511 | $373.15 |
| 71101 | <1% | 48 | $355.14 | |
| 87807 | <1% | 122 | $348.42 | |
| 87075 | <1% | 120 | $344.05 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,884 | $340.88 |
| 77065 | Tomosynthesis, mammo | <1% | 38 | $327.55 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 294 | $292.40 |
| 85018 | <1% | 74 | $272.95 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 2,535 | $270.95 |
| 76377 | <1% | 1,293 | $268.91 | |
| 82653 | <1% | 13 | $257.36 | |
| 80051 | <1% | 44 | $251.53 | |
| 64636 | <1% | 98 | $250.72 | |
| 86480 | <1% | 12 | $222.95 | |
| 90656 | <1% | 29 | $220.40 | |
| 83615 | <1% | 27 | $190.91 | |
| 83993 | <1% | 14 | $189.05 | |
| 88720 | <1% | 14 | $170.68 | |
| 77066 | Tomosynthesis, mammo | <1% | 14 | $144.31 |
| 82962 | <1% | 2,426 | $134.54 | |
| 82075 | <1% | 21 | $133.01 | |
| 82272 | <1% | 28 | $127.00 | |
| A9270 | Non-covered item or service | <1% | 8,441 | $120.18 |
| 82247 | <1% | 22 | $112.93 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 682 | $110.16 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 461 | $109.49 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,026 | $105.88 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 319 | $92.96 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 188 | $91.53 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,194 | $90.78 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,375 | $82.39 |
| 86800 | <1% | 12 | $77.52 | |
| 29125 | <1% | 19 | $75.90 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 860 | $72.65 |
| 51701 | <1% | 19 | $71.56 | |
| 85045 | <1% | 17 | $68.36 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,139 | $66.45 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 866 | $62.90 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 433 | $61.63 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 250 | $60.63 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 378 | $59.19 |
| 82140 | <1% | 16 | $57.32 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 858 | $54.41 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,698 | $49.62 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,034 | $45.05 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 774 | $37.32 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,775 | $35.87 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 549 | $34.39 |
| 82947 | <1% | 14 | $34.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 609 | $30.58 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 913 | $25.40 |
| 87270 | <1% | 25 | $22.86 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 358 | $15.04 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 224 | $9.83 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 189 | $9.66 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 102 | $8.46 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 89 | $5.56 |
| 91300 | <1% | 567 | $5.33 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | <1% | 86 | $3.60 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 178 | $2.28 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 178 | $1.77 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 26 | $1.02 |
| 82010 | 0% | 70 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 180 | $0.00 |
| 00811 | 0% | 572 | $0.00 | |
| C1729 | Catheter, drainage | 0% | 195 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 72 | $0.00 |
| C1780 | Lens, intraocular (new technology) | 0% | 17 | $0.00 |
| 64495 | 0% | 55 | $0.00 | |
| H2017 | Psychosocial rehabilitation, billed per 15 minutes | 0% | 37 | $0.00 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 0% | 187 | $0.00 |
| 64494 | 0% | 74 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 44 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 53 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 36 | $0.00 |
| C1769 | Guide wire | 0% | 119 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 17 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 19 | $0.00 |
| 00142 | 0% | 17 | $0.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 60 | $0.00 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 19 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRILEY, KEVIN (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Firelands Regional Medical Center | Sandusky, OH | $17.59M |
| Firelands Regional Medical Center | Sandusky, OH | $1.81M |
| Central Joint Fire-Ems District | Batavia, OH | $850K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.